[Correction of low-grade and mild myopia using Schwind Excimer laser].
OBJECTIVE
To examine the results of Excimer laser photorefractive keratectomy on myopic eyes. To demonstrate the efficacy, safety, predictability and stability of the Schwind Keratom laser.


METHODS
Two hundred and fifty three patients were operated, with myopia from -0.75 to -8 D and cylinder of less than 1.50 D. Ablation zone diameters were from 5.3 mm to 6.5 m. The follow-up was one year.


RESULTS
One year after the operation, 92% of myopic eyes have uncorrected visual acuity above 20/40, 90% have best corrected visual acuity at least equal to that evaluated before treatment, 94% were within (1 D without correction. Between 6 months and one year, the spherical equivalent varied in only 4% the patients.


CONCLUSIONS
The results with the Schwind Keratom laser are excellent and at least comparable with the other lasers. The best results are obtained with low myopia. At the end of this study, the Schwind Keratom laser was certified in France.
Montard
M
M
Clinique Ophtalmologique, Hôpital Jean-Minjoz, Besançon.
Wannebroucq
S
S
Mutin
P
P
Erbezci
M
M
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007431:Intraoperative Complications; D054018:Lasers, Excimer; D008297:Male; D009216:Myopia / Q000601:surgery*; D018903:Photorefractive Keratectomy; D011183:Postoperative Complications; D011446:Prospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D003907:Dexamethasone
Correction des myopies faibles et moyennes par le laser Excimer Schwind.